The coordinator of the Hereditary Cancer Unit at Gregorio Marañón Hospital takes on the presidency of GEM, a scientific association that brings together healthcare professionals who care for patients with melanoma.
According to lavozmadrid.es, Iván Márquez, coordinator of the Hereditary Cancer Unit at the public Gregorio Marañón Hospital in Madrid, has been appointed president of the Multidisciplinary Spanish Melanoma Group (GEM). The scientific association groups and coordinates healthcare professionals who treat patients with melanoma and promotes research on its diagnosis and treatment.
Márquez's research career focuses on melanoma, hereditary cancer, brain tumours, and breast cancer. He participates in phase I and III clinical trials and is the deputy director of the Phase I Unit and the breast cancer unit.
In the academic field, he has been collaborating since 2009 in practical teaching with the Complutense University of Madrid, is a guest lecturer for the master's programme in Immunology, and teaches the Expert in Immuno-oncology course at the University of Navarra. He has co-supervised three doctoral theses.
Márquez is a member of the Spanish Society of Medical Oncology (SEOM), the American Society of Clinical Oncology (ASCO), the Society for Immunotherapy of Cancer (SITC), and the melanoma group of the European Society of Medical Oncology (ESMO). He has published over 80 articles and presented more than 100 papers at conferences.
The appointment, according to the Community of Madrid, recognises his healthcare and research work in melanoma and the development of new therapeutic strategies in oncology.




